Cite
Molecularly imprinted solid-phase extraction for the selective determination of methamphetamine, amphetamine, and methylenedioxyphenylalkylamine designer drugs in human whole blood by gas chromatography-mass spectrometry.
MLA
Kumazawa, Takeshi, et al. “Molecularly Imprinted Solid-Phase Extraction for the Selective Determination of Methamphetamine, Amphetamine, and Methylenedioxyphenylalkylamine Designer Drugs in Human Whole Blood by Gas Chromatography-Mass Spectrometry.” Journal of Separation Science, vol. 35, no. 5–6, Mar. 2012, pp. 726–33. EBSCOhost, https://doi.org/10.1002/jssc.201100924.
APA
Kumazawa, T., Hasegawa, C., Hara, K., Uchigasaki, S., Lee, X.-P., Seno, H., Suzuki, O., & Sato, K. (2012). Molecularly imprinted solid-phase extraction for the selective determination of methamphetamine, amphetamine, and methylenedioxyphenylalkylamine designer drugs in human whole blood by gas chromatography-mass spectrometry. Journal of Separation Science, 35(5–6), 726–733. https://doi.org/10.1002/jssc.201100924
Chicago
Kumazawa, Takeshi, Chika Hasegawa, Kenji Hara, Seisaku Uchigasaki, Xiao-Pen Lee, Hiroshi Seno, Osamu Suzuki, and Keizo Sato. 2012. “Molecularly Imprinted Solid-Phase Extraction for the Selective Determination of Methamphetamine, Amphetamine, and Methylenedioxyphenylalkylamine Designer Drugs in Human Whole Blood by Gas Chromatography-Mass Spectrometry.” Journal of Separation Science 35 (5–6): 726–33. doi:10.1002/jssc.201100924.